Indutrade AB (0H30)
London Stock Exchange · UK · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 256.00 |
|---|---|
| 52-week range | 180.80 – 270.70 |
| Return, 1 month / 3 months | −0.5% / +6.3% |
| Return, 1 year / 3 years | −2.4% / +39.5% |
| Trend | Uptrend |
| RSI (14) | 48 |
| Volatility (1 year) | 35.8% |
| Worst drawdown (1 year) | -29.0% |
| Average daily value traded | 13.21M SEK |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Indutrade is a Swedish industrial group based in Stockholm that owns a large collection of niche technology businesses. These companies supply components, systems, instruments and services to industrial customers across many markets, often serving specialised or demanding applications. Indutrade operates as a long-term owner, acquiring established businesses and supporting their development while leaving day-to-day operations with local management. Its customers range from manufacturers and process industries to other technical users of specialised equipment and know-how.
Indutrade AB trades under the code 0H30 on the London Stock Exchange in UK, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Indutrade AB (0H30) trades on the London Stock Exchange in UK. It last closed at SEK 256.00 on 27 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 1,010 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.4% and over the last three months it rose 6.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 82 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.8% | ||
| From 52-week high | -5.4% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.3% | ||
| 6-month return | 24.2% | ||
| 12-month return, skipping the last month | -1.9% | ||
| Stability (higher is calmer) | 50 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.0% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 13.21M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 31 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.0% |
|---|---|
| 1 month | −0.5% |
| 3 months | +6.3% |
| 6 months | +24.2% |
| 1 year | −2.4% |
| 3 years | +39.5% |
| 5 years | +9.4% |
Signals
| 50-day / 200-day average | 252.98 / 225.04 |
|---|---|
| Golden / death cross (60 days) | Golden, 49 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 31.14 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Apr 2026 | SEK 3.1000 |
| 4 Apr 2025 | SEK 3.0000 |
| 10 Apr 2024 | SEK 2.8500 |
| 30 Mar 2023 | SEK 2.6000 |
| 6 Apr 2022 | SEK 2.3000 |
| 14 Apr 2021 | SEK 1.8000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.